搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
FierceBiotech
4 小时
JPM25: Medtronic begins rolling out adaptive brain stimulation for Parkinson’s after EU ...
While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...
FierceBiotech
5 小时
JPM25, Day 1: GSK's billion-dollar bet, Bayer's trial first, Lilly buys Scorpion, and more
It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...
FierceBiotech
12 小时
Fierce Biotech Layoff Tracker 2025: Apellis cuts 40 workers; Barinthus Bio lays off 65% of ...
We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...
FierceBiotech
14 小时
Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial
Fresh from a $400 million series A round, Kailera Therapeutics has shown off phase 2 data on an obesity candidate it believes ...
FierceBiotech
15 小时
JPM25: Guardant Health posts 31% sales gain as cancer blood tests expand
In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total ...
FierceBiotech
19 小时
Blueprint ends work on clinical-stage CDK2 inhibitor but pushes on in breast cancer
Blueprint Medicines is cutting funding to its clinical-stage CDK2 inhibitor even as the Ayvakit-maker pushes forward with ...
FierceBiotech
14 小时
JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project
Illumina and Regeneron are taking stakes in the health data company Truveta to help fund research that may dwarf the efforts ...
FierceBiotech
14 小时
JPM25: AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager
Even before that deal, AbbVie had been showing an interest in the modality, with then-CEO Richard Gonzalez telling analysts ...
FierceBiotech
15 小时
JPM25: Eli Lilly strikes $2.5B Scorpion buyout in twist to breast cancer tale
Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan ...
FierceBiotech
17 小时
JPM25: Kyverna's new CEO sets priorities for cell therapy biotech riding the autoimmune wave
About 100 days into the CEO role at Kyverna Therapeutics, Warner Biddle has determined the strategic priorities for the ...
FierceBiotech
16 小时
Epigenetic biotech raises bumper round to the Tune of $175M to fund entry into clinic
Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds as the ...
FierceBiotech
22 小时
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard ...
In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈